カテゴリ： Inkwood Research, 世界, 部品/材料

ボツリヌス毒素の世界市場2023年〜2032年

■ 英語タイトル：GLOBAL BOTULINUM TOXIN MARKET FORECAST 2023-2032

調査会社Inkwood Research社が発行したリサーチレポート（データ管理コード：INK23JUL004）■ 発行会社/調査会社：Inkwood Research
■ 商品コード：INK23JUL004
■ 発行日：2023年5月8日
■ 調査対象地域：グローバル
■ 産業分野：化学
■ ページ数：233
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール
■ 販売価格オプション（消費税別）
Single UserUSD2,500 ⇒換算￥380,000見積依頼/購入/質問フォーム
Multi LicenseUSD3,000 ⇒換算￥456,000見積依頼/購入/質問フォーム
Enterprisewide PriceUSD4,500 ⇒換算￥684,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Inkwood Research社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[ボツリヌス毒素の世界市場2023年〜2032年]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

インクウッドリサーチ社の本調査レポートでは、ボツリヌス毒素の世界市場が予測期間中（2023年〜2032年）に年平均10.07%で成長すると予想しています。本書は、ボツリヌス毒素の世界市場について徹底的に調査を行い、調査範囲・調査手法、エグゼクティブサマリー、市場動向、主要分析、種類別（A型ボツリヌス毒素、B型ボツリヌス毒素）分析、使用人口統計別（女性、男性）分析、用途別（医療用、美容用）分析、エンドユーザー別（専門＆皮膚科医院、病院・診療所、その他）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東/アフリカ、アメリカ、カナダ、イギリス、ドイツ、フランス、イタリア、スペイン、中国、日本、インド、韓国、シンガポール、その他地域）分析、競争状況など、以下の構成でまとめています。なお、ABBVIE、CANDELA MEDICAL、DAEWOONG PHARMACEUTICAL CO LTD、EVOLUS INC、GALDERMA、HUGEL INC、IPSENなどの参入企業情報を含んでいます。
・調査範囲・調査手法
・エグゼクティブサマリー
・市場動向
・主要分析
・世界のボツリヌス毒素市場規模：種類別
- A型ボツリヌス毒素の市場規模
- B型ボツリヌス毒素の市場規模
・世界のボツリヌス毒素市場規模：使用人口統計別
- 女性における市場規模
- 男性における市場規模
・世界のボツリヌス毒素市場規模：用途別
- 医療用ボツリヌス毒素の市場規模
- 美容用ボツリヌス毒素の市場規模
・世界のボツリヌス毒素市場規模：エンドユーザー別
- 専門＆皮膚科医院における市場規模
- 病院・診療所における市場規模
- その他エンドユーザーにおける市場規模
・世界のボツリヌス毒素市場規模：地域別
- 北米のボツリヌス毒素市場規模
- ヨーロッパのボツリヌス毒素市場規模
- アジア太平洋のボツリヌス毒素市場規模
- 中南米のボツリヌス毒素市場規模
- 中東/アフリカのボツリヌス毒素市場規模
- アメリカのボツリヌス毒素市場規模
- カナダのボツリヌス毒素市場規模
- イギリスのボツリヌス毒素市場規模
- ドイツのボツリヌス毒素市場規模
- フランスのボツリヌス毒素市場規模
- イタリアのボツリヌス毒素市場規模
- スペインのボツリヌス毒素市場規模
- 中国のボツリヌス毒素市場規模
- 日本のボツリヌス毒素市場規模
- インドのボツリヌス毒素市場規模
- 韓国のボツリヌス毒素市場規模
- シンガポールのボツリヌス毒素市場規模
- その他地域のボツリヌス毒素市場規模
・競争状況

KEY FINDINGS
The global botulinum toxin market is predicted to record a 10.07% CAGR during the forecast period, 2023-2032. The surge in demand for aesthetic procedures, the rising geriatric population, and the demand for non-invasive cosmetic procedures driving the botulinum toxin market drive the market growth.

MARKET INSIGHTS
Botulinum toxin is a neurotoxin produced by certain Clostridium botulinum strains and is utilized for both therapeutic and cosmetic purposes. Its cosmetic form, commonly referred to as Botox by patients, is an injectable that temporarily reduces or eliminates wrinkles and fine lines on the face. The most frequently treated areas include frown lines, forehead wrinkles, and crow’s feet around the eyes, but it is also used to treat other areas such as gummy smiles, lip lines, overactive jaw muscles, and thick neck bands.
Several factors, including increasing demand for aesthetic procedures, growth in non-invasive cosmetic procedures, research and development initiatives, and a rise in the geriatric population, are propelling the global market for botulinum toxin. With an increasing number of people worldwide undergoing aesthetic procedures each year, the market for botulinum toxin is expected to experience significant growth in the coming years.

REGIONAL INSIGHTS
The global botulinum toxin market analysis comprises a study of Europe, Asia-Pacific, North America, and Rest of World. North America is expected to dominate the market due to the growing R&D efforts to broaden therapeutic uses and an increase in cosmetic issues like crow’s feet and medial canthal wrinkles. Additionally, factors such as disposable personal income and per capita disposable income in the United States are expected to fuel the growth of the botulinum toxin market in North America.

COMPETITIVE INSIGHTS
Market players invest in R&D, label extension, and acquisitions to enhance product offerings. Innovation, advertising, competitive strategies, and high concentration ratio increase industry rivalry.
Major market players include Medytox, Merz Pharma, Lanzhou Institute of Biological Products Co Ltd, etc.

Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation caters to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

TABLE OF CONTENTS
1. RESEARCH SCOPE & METHODOLOGY
1.1. STUDY OBJECTIVES
1.2. METHODOLOGY
1.3. ASSUMPTIONS & LIMITATIONS
2. EXECUTIVE SUMMARY
2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW
2.3. SCOPE OF STUDY
2.4. CRISIS SCENARIO ANALYSIS
2.4.1. IMPACT OF COVID-19 ON BOTULINUM TOXIN MARKET
2.5. MAJOR MARKET FINDINGS
2.5.1. FAVORABLE REGULATORY APPROVALS ADD TO MARKET GROWTH
2.5.2. GROWING AWARENESS ABOUT ‘NOTOX’
2.5.3. INFLATING COSMETIC TOURISM ADDS TO THE DEMAND FOR BOTULINUM TOXIN
3. MARKET DYNAMICS
3.1. KEY DRIVERS
3.1.1. SURGE IN DEMAND FOR AESTHETIC PROCEDURES
3.1.2. RISING GERIATRIC POPULATION
3.1.3. GROWING DEMAND FOR NON-INVASIVE COSMETIC PROCEDURES
3.2. KEY RESTRAINTS
3.2.1. CONCERNS REGARDING THE ADVERSE EFFECTS OF BOTULINUM TOXIN
3.2.2. LACK OF REIMBURSEMENT POLICIES SUPPORTING COSMETIC PROCEDURES
4. KEY ANALYTICS
4.1. KEY MARKET TRENDS
4.2. PORTER’S FIVE FORCES ANALYSIS
4.2.1. BUYERS POWER
4.2.2. SUPPLIERS POWER
4.2.3. SUBSTITUTION
4.2.4. NEW ENTRANTS
4.2.5. INDUSTRY RIVALRY
4.3. GROWTH PROSPECT MAPPING
4.3.1. GROWTH PROSPECT MAPPING FOR UNITED STATES
4.3.2. GROWTH PROSPECT MAPPING FOR GERMANY
4.3.3. GROWTH PROSPECT MAPPING FOR CHINA
4.3.4. GROWTH PROSPECT MAPPING FOR BRAZIL
4.4. MARKET MATURITY ANALYSIS
4.5. MARKET CONCENTRATION ANALYSIS
5. MARKET BY TYPE
5.1. TYPE A BOTULINUM TOXIN
5.2. TYPE B BOTULINUM TOXIN
6. MARKET BY USER DEMOGRAPHIC
6.1. WOMEN
6.2. MEN
7. MARKET BY APPLICATION
7.1. MEDICAL
7.1.1. CHRONIC MIGRAINE
7.1.2. MUSCLE SPASM
7.1.3. OVERACTIVE BLADDER
7.1.4. HYPERHIDROSIS
7.1.5. OTHER MEDICAL APPLICATIONS
7.2. AESTHETIC
7.2.1. CROW’S FEET
7.2.2. FOREHEAD LINES
7.2.3. FROWN LINES/GLABELLAR
7.2.4. SQUARE JAW/MASSETER
7.2.5. OTHER AESTHETIC APPLICATIONS
8. MARKET BY END-USER
8.1. SPECIALTY AND DERMATOLOGY CLINICS
8.2. HOSPITALS AND CLINICS
8.3. OTHER END-USERS
9. GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1. MARKET SIZE & ESTIMATES
9.1.2. NORTH AMERICA BOTULINUM TOXIN MARKET DRIVERS
9.1.3. NORTH AMERICA BOTULINUM TOXIN MARKET CHALLENGES
9.1.4. NORTH AMERICA BOTULINUM TOXIN MARKET REGULATORY FRAMEWORK
9.1.5. KEY PLAYERS IN NORTH AMERICA BOTULINUM TOXIN MARKET
9.1.6. COUNTRY ANALYSIS
9.1.6.1. UNITED STATES
9.1.6.1.1. UNITED STATES BOTULINUM TOXIN MARKET SIZE & OPPORTUNITIES
9.1.6.2. CANADA
9.1.6.2.1. CANADA BOTULINUM TOXIN MARKET SIZE & OPPORTUNITIES
9.2. EUROPE
9.2.1. MARKET SIZE & ESTIMATES
9.2.2. EUROPE BOTULINUM TOXIN MARKET DRIVERS
9.2.3. EUROPE BOTULINUM TOXIN MARKET CHALLENGES
9.2.4. EUROPE BOTULINUM TOXIN MARKET REGULATORY FRAMEWORK
9.2.5. KEY PLAYERS IN EUROPE BOTULINUM TOXIN MARKET
9.2.6. COUNTRY ANALYSIS
9.2.6.1. UNITED KINGDOM
9.2.6.1.1. UNITED KINGDOM BOTULINUM TOXIN MARKET SIZE & OPPORTUNITIES
9.2.6.2. GERMANY
9.2.6.2.1. GERMANY BOTULINUM TOXIN MARKET SIZE & OPPORTUNITIES
9.2.6.3. FRANCE
9.2.6.3.1. FRANCE BOTULINUM TOXIN MARKET SIZE & OPPORTUNITIES
9.2.6.4. ITALY
9.2.6.4.1. ITALY BOTULINUM TOXIN MARKET SIZE & OPPORTUNITIES
9.2.6.5. SPAIN
9.2.6.5.1. SPAIN BOTULINUM TOXIN MARKET SIZE & OPPORTUNITIES
9.2.6.6. NORDIC COUNTRIES
9.2.6.6.1. NORDIC COUNTRIES BOTULINUM TOXIN MARKET SIZE & OPPORTUNITIES
9.2.6.7. POLAND
9.2.6.7.1. POLAND BOTULINUM TOXIN MARKET SIZE & OPPORTUNITIES
9.2.6.8. REST OF EUROPE
9.2.6.8.1. REST OF EUROPE BOTULINUM TOXIN MARKET SIZE & OPPORTUNITIES
9.3. ASIA-PACIFIC
9.3.1. MARKET SIZE & ESTIMATES
9.3.2. ASIA-PACIFIC BOTULINUM TOXIN MARKET DRIVERS
9.3.3. ASIA-PACIFIC BOTULINUM TOXIN MARKET CHALLENGES
9.3.4. ASIA-PACIFIC BOTULINUM TOXIN MARKET REGULATORY FRAMEWORK
9.3.5. KEY PLAYERS IN ASIA-PACIFIC BOTULINUM TOXIN MARKET
9.3.6. COUNTRY ANALYSIS
9.3.6.1. CHINA
9.3.6.1.1. CHINA BOTULINUM TOXIN MARKET SIZE & OPPORTUNITIES
9.3.6.2. JAPAN
9.3.6.2.1. JAPAN BOTULINUM TOXIN MARKET SIZE & OPPORTUNITIES
9.3.6.3. INDIA
9.3.6.3.1. INDIA BOTULINUM TOXIN MARKET SIZE & OPPORTUNITIES
9.3.6.4. SOUTH KOREA
9.3.6.4.1. SOUTH KOREA BOTULINUM TOXIN MARKET SIZE & OPPORTUNITIES
9.3.6.5. SINGAPORE
9.3.6.5.1. SINGAPORE BOTULINUM TOXIN MARKET SIZE & OPPORTUNITIES
9.3.6.6. THAILAND
9.3.6.6.1. THAILAND BOTULINUM TOXIN MARKET SIZE & OPPORTUNITIES
9.3.6.7. AUSTRALIA & NEW ZEALAND
9.3.6.7.1. AUSTRALIA & NEW ZEALAND BOTULINUM TOXIN MARKET SIZE & OPPORTUNITIES
9.3.6.8. REST OF ASIA-PACIFIC
9.3.6.8.1. REST OF ASIA-PACIFIC BOTULINUM TOXIN MARKET SIZE & OPPORTUNITIES
9.4. REST OF WORLD
9.4.1. MARKET SIZE & ESTIMATES
9.4.2. REST OF WORLD BOTULINUM TOXIN MARKET DRIVERS
9.4.3. REST OF WORLD BOTULINUM TOXIN MARKET CHALLENGES
9.4.4. REST OF WORLD BOTULINUM TOXIN REGULATORY FRAMEWORK
9.4.5. KEY PLAYERS IN REST OF WORLD BOTULINUM TOXIN MARKET
9.4.6. REGIONAL ANALYSIS
9.4.6.1. LATIN AMERICA
9.4.6.1.1. LATIN AMERICA BOTULINUM TOXIN MARKET SIZE & OPPORTUNITIES
9.4.6.2. MIDDLE EAST & AFRICA
9.4.6.2.1. MIDDLE EAST & AFRICA BOTULINUM TOXIN MARKET SIZE & OPPORTUNITIES
10. COMPETITIVE LANDSCAPE
10.1. KEY STRATEGIC DEVELOPMENTS
10.1.1. ACQUISITIONS
10.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
10.1.3. PARTNERSHIPS
10.1.4. BUSINESS EXPANSIONS
10.2. COMPANY PROFILES
10.2.1. ABBVIE
10.2.1.1. COMPANY OVERVIEW
10.2.1.2. PRODUCT LIST
10.2.1.3. STRENGTHS & CHALLENGES
10.2.2. CANDELA MEDICAL
10.2.2.1. COMPANY OVERVIEW
10.2.2.2. PRODUCT LIST
10.2.2.3. STRENGTHS & CHALLENGES
10.2.3. DAEWOONG PHARMACEUTICAL CO LTD
10.2.3.1. COMPANY PROFILE
10.2.3.2. PRODUCT LIST
10.2.3.3. STRENGTHS & CHALLENGES
10.2.4. EVOLUS INC
10.2.4.1. COMPANY OVERVIEW
10.2.4.2. PRODUCT LIST
10.2.4.3. STRENGTHS & CHALLENGES
10.2.5. GALDERMA
10.2.5.1. COMPANY OVERVIEW
10.2.5.2. PRODUCT LIST
10.2.5.3. STRENGTHS & CHALLENGES
10.2.6. HUGEL INC
10.2.6.1. COMPANY OVERVIEW
10.2.6.2. PRODUCT LIST
10.2.6.3. STRENGTHS & CHALLENGES
10.2.7. IPSEN
10.2.7.1. COMPANY OVERVIEW
10.2.7.2. PRODUCTS / SERVICES LIST
10.2.7.3. STRENGTHS & CHALLENGES
10.2.8. LANZHOU INSTITUTE OF BIOLOGICAL PRODUCTS CO LTD
10.2.8.1. COMPANY OVERVIEW
10.2.8.2. PRODUCT LIST
10.2.8.3. STRENGTHS & CHALLENGES
10.2.9. MEDYTOX INC
10.2.9.1. COMPANY OVERVIEW
10.2.9.2. PRODUCT LIST
10.2.9.3. STRENGTHS & CHALLENGES
10.2.10. MERZ PHARMA
10.2.10.1. COMPANY OVERVIEW
10.2.10.2. PRODUCT LIST
10.2.10.3. STRENGTHS & CHALLENGES
10.2.11. REVANCE THERAPEUTICS INC
10.2.11.1. COMPANY OVERVIEW
10.2.11.2. PRODUCT LIST
10.2.12. US WORLDMEDS LLC
10.2.12.1. COMPANY OVERVIEW
10.2.12.2. PRODUCT LIST

LIST OF TABLES
TABLE 1: MARKET SNAPSHOT – BOTULINUM TOXIN
TABLE 2: EXAMPLE OF COMMERCIALLY AVAILABLE BOTULINUM TOXIN TYPE A FOR AESTHETIC PROCEDURES
TABLE 3: GLOBAL BOTULINUM TOXIN MARKET, BY TYPE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 4: GLOBAL BOTULINUM TOXIN MARKET, BY TYPE, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 5: GLOBAL TYPE A BOTULINUM TOXIN MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 6: GLOBAL TYPE A BOTULINUM TOXIN MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 7: GLOBAL TYPE B BOTULINUM TOXIN MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 8: GLOBAL TYPE B BOTULINUM TOXIN MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 9: GLOBAL BOTULINUM TOXIN MARKET, BY USER DEMOGRAPHIC, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 10: GLOBAL BOTULINUM TOXIN MARKET, BY USER DEMOGRAPHIC, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 11: GLOBAL WOMEN MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 12: GLOBAL WOMEN MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 13: GLOBAL MEN MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 14: GLOBAL MEN MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 15: GLOBAL BOTULINUM TOXIN MARKET, BY APPLICATION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 16: GLOBAL BOTULINUM TOXIN MARKET, BY APPLICATION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 17: GLOBAL MEDICAL MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 18: GLOBAL MEDICAL MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 19: GLOBAL BOTULINUM TOXIN MARKET, BY MEDICAL, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 20: GLOBAL BOTULINUM TOXIN MARKET, BY MEDICAL, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 21: GLOBAL CHRONIC MIGRAINE MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 22: GLOBAL CHRONIC MIGRAINE MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 23: GLOBAL MUSCLE SPASM MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 24: GLOBAL MUSCLE SPASM MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 25: GLOBAL OVERACTIVE BLADDER MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 26: GLOBAL OVERACTIVE BLADDER MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 27: GLOBAL HYPERHIDROSIS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 28: GLOBAL HYPERHIDROSIS MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 29: GLOBAL OTHER MEDICAL APPLICATIONS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 30: GLOBAL OTHER MEDICAL APPLICATIONS MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 31: GLOBAL AESTHETIC MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 32: GLOBAL AESTHETIC MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 33: GLOBAL BOTULINUM TOXIN MARKET, BY AESTHETIC, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 34: GLOBAL BOTULINUM TOXIN MARKET, BY AESTHETIC, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 35: GLOBAL CROW’S FEET MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 36: GLOBAL CROW’S FEET MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 37: GLOBAL FOREHEAD LINES MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 38: GLOBAL FOREHEAD LINES MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 39: GLOBAL FROWN LINES/GLABELLAR MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 40: GLOBAL FROWN LINES/GLABELLAR MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 41: GLOBAL SQUARE JAW/MASSETER MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 42: GLOBAL SQUARE JAW/MASSETER MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 43: GLOBAL OTHER AESTHETIC APPLICATIONS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 44: GLOBAL OTHER AESTHETIC APPLICATIONS MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 45: GLOBAL BOTULINUM TOXIN MARKET, BY END-USER, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 46: GLOBAL BOTULINUM TOXIN MARKET, BY END-USER, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 47: GLOBAL SPECIALTY AND DERMATOLOGY CLINICS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 48: GLOBAL SPECIALTY AND DERMATOLOGY CLINICS MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 49: GLOBAL HOSPITALS AND CLINICS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 50: GLOBAL HOSPITALS AND CLINICS MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 51: GLOBAL OTHER END-USERS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 52: GLOBAL OTHER END-USERS MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 53: GLOBAL BOTULINUM TOXIN MARKET, BY GEOGRAPHY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 54: GLOBAL BOTULINUM TOXIN MARKET, BY GEOGRAPHY, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 55: NORTH AMERICA BOTULINUM TOXIN MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 56: NORTH AMERICA BOTULINUM TOXIN MARKET, BY COUNTRY, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 57: NORTH AMERICA BOTULINUM TOXIN MARKET REGULATORY FRAMEWORK
TABLE 58: KEY PLAYERS OPERATING IN NORTH AMERICA BOTULINUM TOXIN MARKET
TABLE 59: EUROPE BOTULINUM TOXIN MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 60: EUROPE BOTULINUM TOXIN MARKET, BY COUNTRY, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 61: EUROPE BOTULINUM TOXIN MARKET REGULATORY FRAMEWORK
TABLE 62: KEY PLAYERS OPERATING IN EUROPE BOTULINUM TOXIN MARKET
TABLE 63: ASIA-PACIFIC BOTULINUM TOXIN MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 64: ASIA-PACIFIC BOTULINUM TOXIN MARKET, BY COUNTRY, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 65: ASIA-PACIFIC BOTULINUM TOXIN MARKET REGULATORY FRAMEWORK
TABLE 66: KEY PLAYERS OPERATING IN ASIA-PACIFIC BOTULINUM TOXIN MARKET
TABLE 67: REST OF WORLD BOTULINUM TOXIN MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 68: REST OF WORLD BOTULINUM TOXIN MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 69: REST OF WORLD BOTULINUM TOXIN MARKET REGULATORY FRAMEWORK
TABLE 70: KEY PLAYERS OPERATING IN REST OF WORLD BOTULINUM TOXIN MARKET
TABLE 71: LIST OF ACQUISITIONS
TABLE 72: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 73: LIST OF PARTNERSHIPS
TABLE 74: LIST OF BUSINESS EXPANSIONS


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • ボツリヌス毒素のアジア太平洋市場2023年〜2032年
  • フレキシブルエレクトロニクスの世界市場2023年〜2032年
  • 眼瞼形成術の世界市場2024年〜2032年
  • UV（紫外線）消毒装置の世界市場2023年〜2032年
  • 化学品流通の世界市場2024年〜2032年
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(INK23JUL004 )"ボツリヌス毒素の世界市場2023年〜2032年" (英文：GLOBAL BOTULINUM TOXIN MARKET FORECAST 2023-2032)はInkwood Research社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。